We are live on ! Find out more
NI

Nepsis Inc Portfolio holdings

AUM $295M
1-Year Est. Return 35.44%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+35.44%
3 Year Est. Return
+115.51%
5 Year Est. Return
+196.69%
10 Year Est. Return
+848.99%
AUM
$345M
AUM Growth
+$27.4M
Cap. Flow
+$13.2M
Cap. Flow %
3.83%
Top 10 Hldgs %
54.06%
Holding
32
New
3
Increased
16
Reduced
9
Closed
4

Top Buys

Rank Stock Value
1
NOV icon
NOV
NOV
+$15.1M
2
QCOM icon
Qualcomm
QCOM
+$14.8M
3
CI icon
Cigna
CI
+$13M
4
FFIV icon
F5
FFIV
+$4.75M
5
GIS icon
General Mills
GIS
+$2.09M

Sector Composition

Rank Sector Weight
1 Financials 36.75%
2 Healthcare 22.6%
3 Technology 22.13%
4 Energy 12.86%
5 Real Estate 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NHI icon
26
National Health Investors
NHI
$3.72B
$2.66M 0.77%
46,336
+1,384
+3% +$76.6K
JPST icon
27
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$2.54M 0.74%
50,253
-256
-0.5% -$12.9K
SO icon
28
Southern Company
SO
$109B
$1.99M 0.58%
29,058
-951
-3% -$60.6K
DUK icon
29
Duke Energy
DUK
$97.8B
-15,072
Closed -$1.47M
FRSH icon
30
Freshworks
FRSH
$3.14B
-158,513
Closed -$6.77M
GSK icon
31
GSK
GSK
$104B
-18,272
Closed -$873K
VTR icon
32
Ventas
VTR
$48B
-181,762
Closed -$10M

Similar funds

Nepsis Inc's Q4 2021 Portfolio in Review

As of Q4 2021, Nepsis Inc held 32 positions worth $345M, up 8.6% from $317M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Nepsis Inc deployed $13.2M of net new capital in Q4 2021, opening 3 new positions and adding to 16 existing holdings. Its largest new stake was NOV: 1,104,642 shares worth $15M.

By sector, the portfolio is most concentrated in Financials at 37% of assets, down from 40% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Fulgent Genetics, an estimated $8.76M trimmed.

  • Nepsis Inc's largest Q4 2021 buy was NOV: 1,104,642 shares worth $15M.
  • Nepsis Inc added most to F5 in Q4 2021, an estimated $4.75M increase.
  • Nepsis Inc's biggest Q4 2021 reduction was Fulgent Genetics, cutting an estimated $8.76M.
  • Nepsis Inc fully exited Ventas in Q4 2021, selling an estimated $10M.
  • Nepsis Inc's ten largest holdings make up 54% of its $345M portfolio in Q4 2021.
  • Nepsis Inc opened 3 new positions and closed 4 in Q4 2021.
  • Nepsis Inc's portfolio value rose 8.6% quarter-over-quarter to $345M.

Based on Nepsis Inc's 13F filing for Q4 2021, filed 14 Jan 2022.